BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23558127)

  • 1. [A case of tacrolimus plus intensive LCAP therapy combination for refractory ulcerative colitis].
    Matsumoto A; Yajima H; Murata T; Gotou K; Okamoto K; Nishiyama H
    Nihon Shokakibyo Gakkai Zasshi; 2013 Apr; 110(4):639-47. PubMed ID: 23558127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy.
    Nakase H; Mikami S; Matsuura M; Ueno S; Uza N; Inoue S; Kitamura H; Kasahara K; Yoshino T; Takeda Y; Chiba T
    Intern Med; 2007; 46(11):717-20. PubMed ID: 17541222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus in corticosteroid-resistant ulcerative colitis.
    Matsuhashi N; Nakajima A; Watanabe K; Komeno Y; Suzuki A; Ohnishi S; Omata M; Kondo K; Usui Y; Iwadare JI; Watanabe T; Nagawa H; Muto T
    J Gastroenterol; 2000; 35(8):635-40. PubMed ID: 10955604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
    Nagayama K; Takedatsu H; Mitsuyama K; Yamasaki H; Kuwaki K; Yoshioka S; Kobayashi T; Yamauchi R; Kakuma T; Sata M
    Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis.
    Kobayashi T; Matsuoka K; Yokoyama Y; Nakamura T; Ino T; Numata T; Shibata H; Aoki H; Matsuno Y; Hibi T
    J Gastroenterol; 2018 Mar; 53(3):387-396. PubMed ID: 28597225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
    Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
    World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.
    Emmrich J; Petermann S; Nowak D; Beutner I; Brock P; Klingel R; Mausfeld-Lafdhiya P; Liebe S; Ramlow W
    Dig Dis Sci; 2007 Sep; 52(9):2044-53. PubMed ID: 17410456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.
    Yokoyama Y; Matsuoka K; Kobayashi T; Sawada K; Fujiyoshi T; Ando T; Ohnishi Y; Ishida T; Oka M; Yamada M; Nakamura T; Ino T; Numata T; Aoki H; Sakou J; Kusada M; Maekawa T; Hibi T
    J Crohns Colitis; 2014 Sep; 8(9):981-91. PubMed ID: 24556083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.
    Sawada K; Muto T; Shimoyama T; Satomi M; Sawada T; Nagawa H; Hiwatashi N; Asakura H; Hibi T
    Curr Pharm Des; 2003; 9(4):307-21. PubMed ID: 12570823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LEUKOCYTAPHERESIS IN THE MANAGEMENT OF SEVERE STEROID-DEPENDENT ULCERATIVE COLITIS.
    Krznarić Ž; Markoš P; Golubić Ćepulić B; Čuković-Čavka S; Domislović V; Bojanić I; Barišić A; Kekez D
    Acta Clin Croat; 2019 Sep; 58(3):529-534. PubMed ID: 31969767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukocytapheresis for ulcerative colitis].
    Fukunaga K; Sawada K; Chikano S; Ohnishi K; Egashira A; Tanaka J; Nagase K; Satomi M; Shimoyama T
    Nihon Rinsho; 1999 Nov; 57(11):2496-502. PubMed ID: 10572419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocytapheresis therapy for severe ulcerative colitis.
    Sasaki M; Tsujikawa T; Fujiyama Y; Bamba T
    Ther Apher; 1998 May; 2(2):101-4. PubMed ID: 10225708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
    Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between ulcerative colitis patients treated with leukocytapheresis and ulcerative colitis-associated colorectal cancer.
    Kinugasa T; Akagi Y; Murotani K; Romeo K; Yoshida T; Ryu Y; Shiratuchi I; Shirouzu K
    Anticancer Res; 2011 Jul; 31(7):2547-52. PubMed ID: 21873173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis.
    Umehara Y; Kudo M; Kawasaki M
    World J Gastroenterol; 2008 Sep; 14(34):5316-21. PubMed ID: 18785285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukocytapheresis for ulcerative colitis].
    Sawada K; Ohnishi K; Kosaka T; Egashira A; Yamamura M; Satomi M; Shimoyama T
    Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):438-42. PubMed ID: 9168498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: a preliminary study.
    Tsujikawa T; Andoh A; Ogaẃa A; Sonoda A; Yagi Y; Hata K; Sasaki M; Saito Y; Fujiyama Y
    Ther Apher Dial; 2009 Feb; 13(1):14-8. PubMed ID: 19379165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of leukocytapheresis therapy for ulcerative colitis on anemia and hemodynamics.
    Miyamoto H; Okahisa T; Iwaki H; Murata M; Ito S; Nitta Y; Akutagawa M; Kinouchi Y; Ohnishi Y; Oto J; Nishimura M
    Ther Apher Dial; 2007 Feb; 11(1):16-21. PubMed ID: 17309570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Remission by leukocytapheresis for a patient with ulcerative colitis found refractory by conventional drug therapies].
    Sawada K; Ohnishi K; Kosaka T; Egashira A; Kinoshita T; Amano K; Yamamura M; Satomi M; Shimoyama T
    Nihon Rinsho Meneki Gakkai Kaishi; 1997 Apr; 20(2):126-33. PubMed ID: 9178970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis.
    Ashida T; Kohgo Y; Munakata A; Noguchi M; Iizuka B; Endo Y; Hanai H; Yoshikawa T; Matsumoto T; Aoyama N; Matsui T; Mitsuyama K; Hibi T
    Transfus Apher Sci; 2011 Apr; 44(2):113-7. PubMed ID: 21402309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.